Allara Health Raises $26M to Advance Women’s Health Platform

Allara Health has raised $26 million in Series A funding to expand its virtual care platform focused on treating complex hormonal and metabolic conditions like PCOS and endometriosis. The company provides multidisciplinary, coordinated care that includes specialists in endocrinology, nutrition, and primary care to offer comprehensive support for women’s health. With this funding, the 2022 ADAPT finalist aims to enhance patient access, expand its provider network, and further develop its technology to improve care outcomes for women with chronic conditions.

From the press release:

Allara Health offers a virtual care platform for women battling chronic hormonal conditions, such as endometriosis, polycystic ovarian syndrome (PCOS) and hypothyroidism.

Users can access physicians and nurse practitioners specializing in women’s health, nutrition and lifestyle support, personalized care plans, and metabolic and hormonal blood tests and imaging.

The company will use the funds to accelerate its cross-country expansion in the U.S.

“Allara was built for the tens of millions of women living with complex hormonal and gynecologic conditions across the U.S., myself included,” founder and CEO Rachel Blank said in a statement.

“After receiving a PCOS diagnosis without sufficient medical support, I realized firsthand the inequities that exist for many of us throughout the healthcare system. At Allara, we ensure women struggling with hormonal conditions can access affordable care that answers questions, minimizes symptoms, and helps them live fulfilling lives – and we are incredibly grateful for the support from our investors as we deliver on this mission.”